← Back to headlines
Johnson & Johnson to Invest $1 Billion in New CGT Manufacturing Site in Pennsylvania
Johnson & Johnson plans to construct a new $1 billion cell and gene therapy manufacturing facility in Pennsylvania, expanding its production capabilities.
19 Feb, 12:02 — 19 Feb, 12:02
ℹOnly 1 source covers this story
